p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes
about
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Chlorogenic acid analogues from Gynura nepalensis protect H9c2 cardiomyoblasts against H2O2-induced apoptosisgp-91 mediates histone deacetylase inhibition-induced cardioprotection.Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibitionHyperthermia differently affects connexin43 expression and gap junction permeability in skeletal myoblasts and HeLa cells.Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesRole of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart TransplantationCaveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytesEffect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats.Myocardial AKT: the omnipresent nexus.Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion.Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways.Signaling Pathways in Cardiac Myocyte Apoptosis.Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells.Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling.Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia-reperfusion.Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor.Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3.Human adipose tissue-derived stem cells protect impaired cardiomyocytes from hypoxia/reoxygenation injury through hypoxia-induced paracrine mechanism.Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways.Cucurbitacin I Protects H9c2 Cardiomyoblasts against H2O2-Induced Oxidative Stress via Protection of Mitochondrial Dysfunction.Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction.SIRT1 modulates MAPK pathways in ischemic–reperfused cardiomyocytes
P2860
Q28296128-F8595A6B-A397-4236-A869-A2580C82074CQ32186803-59B16A0E-A130-4340-AE1E-5AEBF41A26BDQ33892798-E6C7B032-B8DE-46F5-BA6D-0DB33822AD9DQ33917016-7C0BA9B4-7DAC-4537-BC4B-23FDAFC768EFQ34038093-47A5182D-939D-4144-8071-392C4B96799EQ34289211-84F5B341-9077-4BBA-B2D2-07B62DE6A9EDQ35864123-D897D57D-7434-4DEF-B5F9-A16443F139E4Q36617132-F5B0C521-EE88-4ED0-B7A4-D226A8D185E4Q36733190-791D0E50-4130-42DE-B67A-6B7381BC10E3Q36908289-9A10955B-CB3D-43A7-84A7-641412301432Q37070078-DF952D66-2667-4118-B6E5-FC24938C6BE9Q37316394-C84B4521-7B96-47C5-8C53-CAB6DA7FA47FQ37934996-09487F30-1B46-42DD-87BE-C7EC7A8CEAC3Q38768739-0B4FD416-4A29-474E-A785-C40081AE9806Q38906550-C2E44BBA-B4C4-4D0C-A3AE-19C08715D441Q39410853-EF10EBCC-09CC-405A-BF3D-1C8AF3F678D1Q39780536-E3F9CC0D-DDA3-4CB9-91EF-A3C09F8784A6Q39946205-E01D1388-A09C-412D-9BBC-13FB5DE74D89Q40435871-B6521CC5-3B3A-411F-9B40-F08F08398AD2Q41954132-CD648300-D30C-445B-AF31-2F19401AA050Q42285882-0FCFBC04-C588-4377-91D0-1BB6FCC810CAQ44080664-C0E5BF05-86AD-4ED3-A2BE-8A9BE3F7FEC2Q46186834-67D9588C-51CB-4B67-9B36-240FB4C5C27AQ47310567-FDA4FFFC-824E-4C3A-AF3E-5B6F52EDE53CQ47355559-53FF6BE9-2F08-4392-998F-C0AAC3432078Q48095584-3FF1CCE8-E878-4922-A0E6-63DC45CDA236Q54114905-CC3AE40F-207B-4FB3-A6BB-70E36E78E7CDQ54168051-BDE868B3-3BC4-4E42-98E2-B6025B03B9FFQ58290942-2041AA97-4038-49F6-9762-4E5122A53BBE
P2860
p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes
description
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juni 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/09/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/09/01)
@nl
наукова стаття, опублікована у вересні 2004
@uk
مقالة علمية (نشرت في سبتمبر 2004)
@ar
name
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@ast
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@en
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@nl
type
label
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@ast
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@en
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@nl
prefLabel
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@ast
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@en
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@nl
P3181
P1476
p38 and JNK have distinct regu ...... ion in neonatal cardiomyocytes
@en
P2093
P2888
P304
P3181
P356
10.1007/S00395-004-0478-3
P577
2004-06-14T00:00:00Z
P6179
1028715250